Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study

Author： Di Carlo Costantino   Gargano Virginia   Sparice Stefania   Tommaselli Giovanni A.   Bifulco Giuseppe   Nappi Carmine  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.29, Iss.12, 2013-12, pp. : 1048-1050

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The use of an oral contraceptive containing estradiol valerate and dienogest before office operative hysteroscopy: a feasibility study

By Bifulco Giuseppe   Sardo Attilio Di Spiezio   De Rosa Nicoletta   Greco Elena   Spinelli Marialuigia   Di Carlo Costantino   Tommaselli Giovanni A.   Nappi Carmine  

Gynecological Endocrinology, Vol. 28, Iss. 12, 2012-12 ,pp. : 949-955

Informa Healthcare

Access to resources Recommend Favorite

An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest

By Fruzzetti Franca   Trémollieres Florence   Bitzer Johannes  

Gynecological Endocrinology, Vol. 28, Iss. 5, 2012-05 ,pp. : 400-408

Informa Healthcare

Access to resources Recommend Favorite

The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: A clinical trial

By Pirimoglu Meltem Z.   Aygun Elif   Dansuk Ramazan   Kucukercan Inci   Unal Orhan   Turan Cem  

Gynecological Endocrinology, Vol. 21, Iss. 3, 2005-09 ,pp. : 185-188

Informa Healthcare

Access to resources Recommend Favorite

Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women

By Hietala M.   Sandberg T.   Borg Å.   Olsson H.   Jernström H.  

Human Reproduction, Vol. 22, Iss. 1, 2007-01 ,pp. : 83-91

Oxford University Press

Access to resources Recommend Favorite

Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 µg ethinyl estradiol and 3 mg drospirenone

By Milsom I.   Lete I.   Bjertnaes A.   Rokstad K.   Lindh I.   Gruber C.J.   Birkhäuser M.H.   Aubeny E.   Knudsen T.   Bastianelli C.  

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2304-2311

Oxford University Press

Access to resources Recommend Favorite